Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology

BACKGROUND: The development of novel antitumor agents and accompanying biomarkers has improved survival across several tumor types. Previously, we published provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors. Recently, effica...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Clin Oncol
Main Authors: Naito, Yoichi, Mishima, Saori, Akagi, Kiwamu, Igarashi, Ataru, Ikeda, Masafumi, Okano, Susumu, Kato, Shunsuke, Takano, Tadao, Tsuchihara, Katsuya, Terashima, Keita, Nishihara, Hiroshi, Nishiyama, Hiroyki, Hiyama, Eiso, Hirasawa, Akira, Hosoi, Hajime, Maeda, Osamu, Yatabe, Yasushi, Okamoto, Wataru, Ono, Shigeru, Kajiyama, Hiroaki, Nagashima, Fumio, Hatanaka, Yutaka, Miyachi, Mitsuru, Kodera, Yasuhiro, Yoshino, Takayuki, Taniguchi, Hiroya
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Singapore 2020
Assuntos:
Special Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7046581/
https://ncbi.nlm.nih.gov/pubmed/31974683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10147-019-01610-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados